Curocell Seeks Approval to Amend Phase 3 Lymphoma Trial Plan
Curocell applied to South Korea's Ministry of Food and Drug Safety for approval to amend its Phase 3 lymphoma trial plan.
Curocell applied to South Korea's Ministry of Food and Drug Safety for approval to amend its Phase 3 lymphoma trial plan.